5/15/24 16:13 | 5/14/24 | LENZ | Lenz Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chevallard Daniel R. | CA | O | CFO | P | 50 | 15.68 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 102 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/27/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.7322 | 0 | -3 | -3 | 102 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/28/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.5000 | 0 | -4 | -4 | 99 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 96 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/28/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.45 | 0 | -4 | -4 | 96 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 92 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.42 | 0 | -4 | -4 | 92 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 89 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/27/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -6 | 1.68 | 0 | -4 | -4 | 89 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/28/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -10 | 2.72 | 0 | -4 | -4 | 86 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/26/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -15 | 4.02 | 0 | -4 | -4 | 82 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 10 | 79 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/26/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -7 | 1.90 | 0 | -4 | -4 | 79 | D | | | | | | | | | | | | | | |
3/1/22 21:10 | 2/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 10 | 76 | D | | | | | | | | | | | | | | |
3/1/22 21:10 | 2/28/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -11 | 2.78 | 0 | -4 | -5 | 76 | D | | | | | | | | | | | | | | |
11/29/21 19:48 | 11/25/21 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 14 | 23 | 73 | D | | | | | | | | | | | | | | |
11/29/21 19:48 | 11/26/21 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.dm | -36 | 4.81 | 0 | -8 | -9 | 73 | D | | | | | | | | | | | | | | |
9/29/21 18:04 | 9/28/21 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 9 | 0.9000 | 0 | 10 | 18 | 67 | D | | | | | | | | | | | | | | |
6/1/21 17:49 | 5/28/21 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 11 | 0.9000 | 0 | 12 | 27 | 57 | D | | | | | | | | | | | | | | |
7/2/19 17:41 | 7/1/19 | RGLS | Regulus Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | S | -4 | 1.31 | 0 | -3 | -3 | 78 | D | | | | | | | | | | | | | | |
5/16/19 17:21 | 5/15/19 | RGLS | Regulus Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | S.d | -14 | 1.41 | 0 | -10 | -11 | 81 | D | | | | | | | | | | | | | | |
4/3/19 16:16 | 4/1/19 | RGLS | Regulus Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | S | -3 | 0.9814 | 0 | -3 | -26 | 9 | D | | | | | | | | | | | | | | |
7/25/17 18:07 | 7/25/17 | RGLS | Regulus Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | P | 50 | 0.9100 | 0 | 55 | 999% | 59 | D | | | | | | | | | | | | | | |